BRIEF published on 05/13/2026 at 07:05, 3 months 12 days ago SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE published on 05/13/2026 at 07:00, 3 months 12 days ago SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026 Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF published on 02/11/2026 at 07:05, 6 months 14 days ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 6 months 14 days ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 6 months 14 days ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 6 months 22 days ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
BRIEF published on 02/03/2026 at 15:05, 6 months 22 days ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
PRESS RELEASE published on 02/03/2026 at 15:00, 6 months 22 days ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 8 months 14 days ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
BRIEF published on 12/11/2025 at 07:05, 8 months 14 days ago SCHOTT Pharma atteint ses objectifs de chiffre d'affaires et de rentabilité pour l'exercice complet. SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Systèmes D'administration De Médicaments Solutions De Confinement Des Médicaments
Published on 08/25/2026 at 23:05, 3 hours 52 minutes ago Faraday Copper Shareholders Approve Share Issuance in Connection with the Acquisition of the San Manuel Project
Published on 08/25/2026 at 15:00, 11 hours 57 minutes ago Four Nines Gold Intersects Hydrothermal Breccia in First Three Holes at Hayden Hill
Published on 08/25/2026 at 14:30, 12 hours 27 minutes ago First Breach Completes First Flight of Drone Prototype and Advances American-Made Manufacturing Through Hellbender Agreement
Published on 08/25/2026 at 14:30, 12 hours 27 minutes ago Tintina Mines Completes Strategic Partnership Transaction, Consolidating 100% Ownership of the Dos Amigos (formerly Domeyko Sulfuros) Copper-Gold Project in Chile
Published on 08/25/2026 at 22:35, 4 hours 22 minutes ago ZOOPUNK Makes Its Opening Night Live Debut at gamescom 2026
Published on 08/25/2026 at 20:35, 6 hours 22 minutes ago Michter's Named the #1 Most Admired Whiskey in the World by Drinks International in New 2026 Ranking
Published on 08/25/2026 at 18:57, 8 hours ago EQS-Adhoc: net digital AG significantly exceeds expectations for revenue and EBITDA in the first half of 2026
Published on 08/25/2026 at 17:45, 9 hours 12 minutes ago EQS-Adhoc: MPC Oceanic Group raises forecast for the financial year 2026
Published on 08/25/2026 at 17:45, 9 hours 12 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 9 hours 12 minutes ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 17:45, 9 hours 12 minutes ago Imerys-08-2026-communique-capital-droits-de-vote-au-31-juilet-2026
Published on 08/25/2026 at 08:30, 18 hours 27 minutes ago Eiffage wins several contracts worth a total of €132 million in the healthcare sector
